Enhancement of renal cGMP levels by administration of sGC stimulator BAY 41–2272 to animals with a progressive renal fibrosis at one week after induction of anti-Thy-1-induced chronic glomerulosclerosis, significantly limited tubulointerstitial fibrosis and preserved renal function [42]. Here, THY1 is linked to renal fibrosis.